Literature DB >> 8651266

Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.

A M Goldstein1, L R Goldin, N C Dracopoli, W H Clark, M A Tucker.   

Abstract

Previous linkage analyses of 19 cutaneous malignant melanoma/dysplastic nevi (CMM/DN) kindreds showed significant evidence of linkage and heterogeneity to both chromosomes 1p and 9p. Five kindreds also showed evidence of linkage (Z>0.7) to both regions. To further examine these findings, we conducted two-trait-locus, two-marker-locus linkage analysis. We examined one homogeneity and one heterogeneity single-locus model (SL-Hom and SL-Het), and two-locus (2L) models: an epistatic model (Ep), in which CMM was treated as a genuine 2L disease, and a heterogeneity model (Het), in which CMM could result from disease alleles at either locus. Both loci were modeled as autosomal dominant. The LOD scores for CMM alone were highest using the SL-Het model (Z = 8.48, theta = .0). There was much stronger evidence of linkage to chromosome 9p than to 1p for CMM alone; the LOD scores were approximately two times greater on 9p than on 1p. The change in LOD scores from an evaluation of CMM alone to CMM/DN suggested that a chromosome 1p locus (or loci) contributed to both CMM and CMM/DN, whereas a 9p locus contributed more to CMM alone. For both 2L models, the LOD scores from 1p were greater for CMM/DN than for CMM alone (Ep: Z=4.63 vs. 3.83; Het: 4.94 vs. 3.80, respectively). In contrast, for 9p, the LOD scores were substantially lower with CMM/DN than with CMM alone (Ep: 4.64 vs. 7.06; Het: 5.38 vs. 7.99, respectively). After conditioning on linkage to the other locus, only the 9p locus consistently showed significant evidence for linkage to CMM alone. Thus, the application of 2L models may be useful to help unravel the complexities of familial melanoma.

Entities:  

Mesh:

Year:  1996        PMID: 8651266      PMCID: PMC1914626     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Exclusion of the dysplastic nevus syndrome (DNS) locus from the short arm of chromosome 1 by linkage studies in Dutch families.

Authors:  A van Haeringen; W Bergman; M R Nelen; E van der Kooij-Meijs; I Hendrikse; J T Wijnen; P M Khan; E C Klasen; R R Frants
Journal:  Genomics       Date:  1989-07       Impact factor: 5.736

2.  Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p.

Authors:  S J Bale; N C Dracopoli; M A Tucker; W H Clark; M C Fraser; B Z Stanger; P Green; H Donis-Keller; D E Housman; M H Greene
Journal:  N Engl J Med       Date:  1989-05-25       Impact factor: 91.245

3.  Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.

Authors:  L Zuo; J Weger; Q Yang; A M Goldstein; M A Tucker; G J Walker; N Hayward; N C Dracopoli
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

4.  A simple scheme for the analysis of HLA linkages in pedigrees.

Authors:  J Ott
Journal:  Ann Hum Genet       Date:  1978-10       Impact factor: 1.670

5.  Mutations associated with familial melanoma impair p16INK4 function.

Authors:  K Ranade; C J Hussussian; R S Sikorski; H E Varmus; A M Goldstein; M A Tucker; M Serrano; G J Hannon; D Beach; N C Dracopoli
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

6.  Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome Ip36.

Authors:  L A Cannon-Albright; D E Goldgar; E C Wright; A Turco; M Jost; L J Meyer; M Piepkorn; J J Zone; M H Skolnick
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

7.  Multilocus linkage analysis in humans: detection of linkage and estimation of recombination.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Am J Hum Genet       Date:  1985-05       Impact factor: 11.025

8.  Dysplastic nevi on the scalp of prepubertal children from melanoma-prone families.

Authors:  M A Tucker; M H Greene; W H Clark; K H Kraemer; M C Fraser; D E Elder
Journal:  J Pediatr       Date:  1983-07       Impact factor: 4.406

9.  Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds.

Authors:  G J Walker; C J Hussussian; J F Flores; J M Glendening; F G Haluska; N C Dracopoli; N K Hayward; J W Fountain
Journal:  Hum Mol Genet       Date:  1995-10       Impact factor: 6.150

10.  A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma.

Authors:  T Wölfel; M Hauer; J Schneider; M Serrano; C Wölfel; E Klehmann-Hieb; E De Plaen; T Hankeln; K H Meyer zum Büschenfelde; D Beach
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

View more
  7 in total

Review 1.  Neurology and the skin.

Authors:  O Hurko; T T Provost
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

Review 2.  Hereditary pancreatic cancer.

Authors:  Shilpa Grover; Sapna Syngal
Journal:  Gastroenterology       Date:  2010-08-19       Impact factor: 22.682

3.  The dysplastic nevus: from historical perspective to management in the modern era: part II. Molecular aspects and clinical management.

Authors:  Keith Duffy; Douglas Grossman
Journal:  J Am Acad Dermatol       Date:  2012-07       Impact factor: 11.527

Review 4.  Molecular aspects of melanocytic dysplastic nevi.

Authors:  Mahmoud Rezk Abd-Elwahed Hussein; Gary Stewart Wood
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

5.  Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma.

Authors:  K Laud; C Marian; M F Avril; M Barrois; A Chompret; A M Goldstein; M A Tucker; P A Clark; G Peters; V Chaudru; F Demenais; A Spatz; M W Smith; G M Lenoir; B Bressac-de Paillerets
Journal:  J Med Genet       Date:  2005-06-03       Impact factor: 6.318

6.  Evidence for a novel late-onset Alzheimer disease locus on chromosome 19p13.2.

Authors:  Ellen M Wijsman; E Warwick Daw; Change-En Yu; Haydeh Payami; Ellen J Steinbart; David Nochlin; Erin M Conlon; Thomas D Bird; Gerard D Schellenberg
Journal:  Am J Hum Genet       Date:  2004-07-08       Impact factor: 11.025

7.  Mutation screening of CHD5 in melanoma-prone families linked to 1p36 revealed no deleterious coding or splice site changes.

Authors:  David Ng; Xiaohong R Yang; Margaret A Tucker; Alisa M Goldstein
Journal:  BMC Res Notes       Date:  2008-09-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.